JP Morgan Healthcare Conference Pierian, Seven Bridges, UgenTec Acquired, Merged to Become Velsera The three firms were acquired by investment fund Summa Equity and merged to form a new Boston-headquartered company. Element Biosciences Points to First Wave of Customer Data at JP Morgan Conference The San Diego-based sequencing instrument maker highlighted data from three customers: the University of California, San Diego; Gencove; and Qiagen. JP Morgan Healthcare Conference, Day 4: Singular Genomics, Quantum-Si, Quanterix On the last day of the conference, Singular Genomics and Quantum-Si provided updates on their recently launched systems while Quanterix addressed its ongoing restructuring. Rebranded GeneDx Bets Future on Whole-Exome, Whole-Genome Sequencing in Pediatric Rare Disease Premium After dropping underdeveloped Sema4 business lines but emphasizing the Centrellis informatics platform, the new GeneDx expects to reach profitability by 2025. SomaLogic Seeks 'Strategic Alternatives' for Dx Business to Focus on Life Science Market The proteomics firm is in talks to either spin off its SomaSignal assays unit or to partner with another company to boost its diagnostics efforts. Jan 12, 2023 JP Morgan Healthcare Conference, Day 3: Invitae, NanoString, Bio-Rad, Olink, More Jan 12, 2023 Pacific Biosciences Provides Updates on Platforms, Contracts at JP Morgan Conference Jan 11, 2023 Ginkgo Bioworks Expects to Meet 2022 Revenue Guidance Despite Foundry Services Shortfall Jan 11, 2023 Evolving Akoya Biosciences Touts CDx Partnerships at JP Morgan Conference Jan 11, 2023 JP Morgan Healthcare Conference, Day 2: Thermo Fisher, Agilent, Roche, Seer, More Jan 11, 2023 Hologic Aims to Expand Global Reach With Focus on Women's Health Jan 11, 2023 PerkinElmer Becoming Pure Play Dx, Life Science Firm, Spurred on by COVID Innovations Jan 11, 2023 Natera Eyes Regulatory Path for Signatera as Companion Diagnostic Jan 10, 2023 JP Morgan Healthcare Conference, Day 1: Guardant Health, Exact Sciences, Bruker, 10x Genomics, More Jan 10, 2023 Myriad Genetics Highlights 2023 Product Launches for Women's Health, Oncology Businesses Premium Jan 10, 2023 Illumina Seeing Strong NovaSeq X Demand, Reports Preliminary Q4 Revenues Down 10 Percent Jan 9, 2023 Qiagen Acquires Forensic Science NGS Firm Verogen for $150M Jan 9, 2023 Preliminary Earnings Roundup: NanoString Technologies, SomaLogic, Pacific Biosciences, More Jan 13, 2022 Pacific Biosciences Outlines Progress on Short-Read Sequencing at JPM, Partners With Canexia Health Jan 13, 2022 NanoString Technologies Touts Interest in CosMx Spatial Biology Platform at JPM Jan 13, 2022 Quanterix Projects Q4 2021 Revenues of $29M to $31M Jan 13, 2022 JPM Healthcare Conference Day 3: Quantum-Si, Olink, Exact Sciences, Bio-Techne, Opko Health, More Jan 13, 2022 Singular Genomics Outlines Launch Plans for G4 Sequencer at JPM Jan 12, 2022 Invitae Launches Ciitizen Genome Information Management Platform at JPM Jan 12, 2022 JPM Healthcare Conference Day 2: Thermo Fisher, BD, SomaLogic, Myriad, Oxford Nanopore, More Load More Breaking News GA4GH Announces 10 New 'Driver' Projects, Including First Pediatric Partner Single-Cell MRD Assay Helps Characterize Cells Surviving Acute Myeloid Leukemia Therapy Research Triangle Institute Partners With GeneDx, Illumina for Expanded Newborn Screening Study Bionano Genomics' Third Chinese OEM Partner Gets NMPA Nod for Sample Prep Product InformedDNA Buys gWell Health, Names New CEO The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.